Hlavní stranaMezinárodní spolupráceOptimization of therapeutic oligonucleotide efficacy for...

Optimization of therapeutic oligonucleotide efficacy for the treatment of solid tumours by innovative nanoparticles

Datum: 27.8.2018 

Summary:

A Dutch clinical stage company is developing a new generation of nanomedicines. Their aim is to use their nanoparticle technology to improve the efficacy and safety profiles of current and novel drugs for the treatment of solid tumours.

As part of their development strategy, they are looking for a license and/or technical cooperation agreement with academic research labs to exploit their nanoparticles for enhanced tumour targeting of new oligonucleotides with therapeutic potential.

Reference: TRNL20180531001

Country: Netherlands

Submitted: 27. 8. 2018

View Partnering Opportunity

 

Keywords

Technology: Clinical Research, Trials, Cytology, Cancerology, Oncology, Medical Research, Pharmaceutical Products / Drugs

Market: Drug delivery and other equipment, Oncology, Pharmaceuticals/fine chemicals

NACE: Research and experimental development on biotechnology, Other human health activities

 


Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.

 


 

OPPI, MPO, EU

Doporučujeme

Biosimilars USA
Czech Bio

CEBIO a I. etapa JVTP

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

Provozovatel

Jihočeská agentura pro podporu inovačního podnikání o.p.s.

Články na přání


[načítám anketu]

LinkedIn